Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Enlaza Therapeutics, Inc. See All Filings	D	2025-09-10 18:35:50 UTC
Amount To Be Raised $15,000,000 Associated Brokers / Dealers N/A CIK Number 0001852950 Filed Document 0001231919-25-000186 Exclusions or Exemptions 506b Accepted Date 2025-09-10 18:35:50 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Enlaza Therapeutics, Inc. See All Filings	D	2024-08-09 16:40:08 UTC
Amount To Be Raised $110,000,000 Associated Brokers / Dealers N/A CIK Number 0001852950 Filed Document 0001852950-24-000001 Exclusions or Exemptions 506b Accepted Date 2024-08-09 16:40:08 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Enlaza Therapeutics, Inc. See All Filings	D/A	2022-11-22 16:20:17 UTC
Amount To Be Raised $61,330,607 Associated Brokers / Dealers N/A CIK Number 0001852950 Filed Document 0001852950-22-000003 Exclusions or Exemptions 506b Accepted Date 2022-11-22 16:20:17 UTC Type of Offering D/A Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Enlaza Therapeutics, Inc. See All Filings	D	2022-10-13 17:04:03 UTC
Amount To Be Raised $311,977 Associated Brokers / Dealers N/A CIK Number 0001852950 Filed Document 0001852950-22-000002 Exclusions or Exemptions 506b Accepted Date 2022-10-13 17:04:03 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Enlaza Therapeutics, Inc. See All Filings	D	2022-10-13 16:34:48 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001852950 Filed Document 0001852950-22-000001 Exclusions or Exemptions 506b Accepted Date 2022-10-13 16:34:48 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Enlaza Therapeutics, Inc. See All Filings	D	2021-08-13 13:44:55 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001852950 Filed Document 0001852950-21-000003 Exclusions or Exemptions 506b Accepted Date 2021-08-13 13:44:55 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Enlaza Therapeutics, Inc. See All Filings	D	2021-06-28 15:07:18 UTC
Amount To Be Raised Indefinite Associated Brokers / Dealers N/A CIK Number 0001852950 Filed Document 0001852950-21-000002 Exclusions or Exemptions 506b Accepted Date 2021-06-28 15:07:18 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Enlaza Therapeutics, Inc. See All Filings	D	2021-03-24 21:40:22 UTC
Amount To Be Raised $21,273,287 Associated Brokers / Dealers N/A CIK Number 0001852950 Filed Document 0001852950-21-000001 Exclusions or Exemptions 506b Accepted Date 2021-03-24 21:40:22 UTC Type of Offering D Industry Pharmaceuticals Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity